HRMY

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Harmony Biosciences Holdings (HRMY) Earnings Date & Reports

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

HRMY is expected to report earnings to fall 43.43% to 61 cents per share on May 06

Harmony Biosciences Holdings HRMY Stock Earnings Reports

Q1'25

Est.

$0.61

Q4'24

Beat

by $0.39

Q3'24

Beat

by $0.12

Q2'24

Beat

by $1.04

Q1'24

Beat

by $0.25

The last earnings report on February 25 showed earnings per share of $1.08, beating the estimate of 68 cents. With 987.14K shares outstanding, the current market capitalization sits at 1.66B.

View a ticker or compare two or three

Compare

HRMY

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For HRMY
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for HRMY (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

630 West Germantown Pike

Phone

+1 484 539-9800

Employees

246

Web

https://www.harmonybiosciences.com